MUNICH, Oct. 1, 2025 /CNW/ -- Vertanical today announced publication of results from two Phase 3 clinical studies investigating the safety and efficacy of VER-01, a first-in-class standardized full-spectrum extract from Cannabis sativa DKJ127 L, for the treatment of chronic low back pain (CLBP). The Phase 3 findings point to a potential therapeutic breakthrough for the treatment of CLBP.
Read more at newswire.caThis article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.